Earnings Call Insights: BioNTech SE (BNTX) Q4 2025
Management View
- CEO Ugur Sahin highlighted that BioNTech maintained its leadership in the COVID vaccine market, launching a variant-adapted vaccine in partnership with Pfizer, now distributed in over 180 countries with more than 50% market